Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.59 |
| ▸ | ITGB3 | P05106 | 8/20 | 0.39 |
| ▸ | ITGA2B | P08514 | 8/20 | 0.39 |
| ▸ | ECE1 | P42892 | 1/20 | 0.37 |
| ▸ | GHSR | Q92847 | 1/20 | 0.36 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.36 |
| ▸ | CALCRL | Q16602 | 2/20 | 0.36 |
| ▸ | NMT2 | O60551 | 1/20 | 0.35 |
| ▸ | NMT1 | P30419 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3948444 | 1.00 | SLC15A2 (0.59) | SLC15A2ITGB3ITGA2BECE1GHSR | |
| SCHEMBL30714838 | 1.00 | SLC15A2 (0.59) | SLC15A2ITGB3ITGA2BECE1GHSR | |
| SCHEMBL29473319 | 0.97 | SLC15A2 (0.63) | SLC15A2ITGB3ITGA2BECE1GHSR | |
| SCHEMBL259085 | 0.96 | SLC15A2 (0.64) | SLC15A2ITGB3ITGA2BECE1GHSR | |
| SCHEMBL10595108 | 0.96 | SLC15A2 (0.64) | SLC15A2ITGB3ITGA2BECE1GHSR | |
| SCHEMBL259084 | 0.96 | SLC15A2 (0.64) | SLC15A2ITGB3ITGA2BECE1GHSR | |
| SCHEMBL5598418 | 0.96 | SLC15A2 (0.64) | SLC15A2ITGB3ITGA2BECE1GHSR | |
| SCHEMBL8832939 | 0.96 | SLC15A2 (0.64) | SLC15A2ITGB3ITGA2BECE1GHSR | |
| SCHEMBL2815080 | 0.95 | SLC15A2 (0.63) | SLC15A2ITGB3ITGA2BECE1GHSR | |
| SCHEMBL4589903 | 0.95 | SLC15A2 (0.63) | SLC15A2ITGB3ITGA2BECE1GHSR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7521477-B2 | Vitamin C derivatives with peptide, preparation method thereof and composition comprising the same | PEPTRON CO., LTD. (KR) | 2009-04-21 | — | — | US | claimed |
| EP-1618125-A4 | VITAMIN C DERIVATIVES WITH PEPTIDE, PREPARATION METHOD THEREOF AND COMPOSITION COMPRISING THE SAME | PEPTRON CO LTD (KR) | 2008-03-26 | — | — | EP | claimed |
| US-20070093425-A1 | Vitamin c derivatives with peptide, preparation method thereof and composition comprising the same | PEPTRON CO., LTD. (KR) | 2007-04-26 | — | — | US | claimed |
| EP-1618125-A1 | VITAMIN C DERIVATIVES WITH PEPTIDE, PREPARATION METHOD THEREOF AND COMPOSITION COMPRISING THE SAME | Petron Co., Ltd. (KR) | 2006-01-25 | — | — | EP | claimed |
| WO-2004096837-A1 | VITAMIN C DERIVATIVES WITH PEPTIDE, PREPARATION METHOD THEREOF AND COMPOSITION COMPRISING THE SAME | PEPTRON CO., LTD (KR) | 2004-11-11 | — | — | WO | claimed |
| WO-2026046854-A1 | PEPTIDE CONTAINING HYDROGEL COMPOSITIONS | THE BOOTS COMPANY PLC (GB) | 2026-03-05 | — | — | WO | disclosed |
| WO-2025215348-A1 | SKIN WOUND TREATMENT | THE BOOTS COMPANY PLC (GB) | 2025-10-16 | — | — | WO | disclosed |
| EP-4631517-A1 | SKIN WOUND TREATMENT | The Boots Company plc (GB) | 2025-10-15 | — | — | EP | disclosed |
| US-20250170043-A1 | KIT OF COSMETIC COMPOSITIONS | THE BOOTS COMPANY PLC (GB) | 2025-05-29 | — | — | US | disclosed |
| US-20250161201-A1 | COSMETIC COMPOSITION | THE BOOTS COMPANY PLC (GB) | 2025-05-22 | — | — | US | disclosed |
| US-20250161200-A1 | COSMETIC COMPOSITION COMPRISING EXTRACT OF OPHIOPOGON JAPONICUS AND AT LEAST ONE CERAMIDE | THE BOOTS COMPANY PLC (GB) | 2025-05-22 | — | — | US | disclosed |
| US-20250152494-A1 | COSMETIC COMPOSITION CONTAINING RETINOID, EXTRACT OF CENTELLA ASIATICA AND A DIPEPTIDE | THE BOOTS COMPANY PLC (GB) | 2025-05-15 | — | — | US | disclosed |
| EP-4140473-A1 | COSMETIC COMPOSITIONS | The Boots Company plc (GB) | 2023-03-01 | — | — | EP | disclosed |
| EP-4140471-A1 | COMPOSITION WITH BIOLOGICALLY ACTIVE AGENT | The Boots Company plc (GB) | 2023-03-01 | — | — | EP | disclosed |
| EP-4141877-A1 | METHOD FOR IDENTIFYING A SOLVENT FOR A MATRIKINE | The Boots Company plc (GB) | 2023-03-01 | — | — | EP | disclosed |
| US-7521477-B2 | Vitamin C derivatives with peptide, preparation method thereof and composition comprising the same | PEPTRON CO., LTD. (KR) | 2009-04-21 | — | — | US | disclosed |
| EP-1618125-A4 | VITAMIN C DERIVATIVES WITH PEPTIDE, PREPARATION METHOD THEREOF AND COMPOSITION COMPRISING THE SAME | PEPTRON CO LTD (KR) | 2008-03-26 | — | — | EP | disclosed |
| US-20070093425-A1 | Vitamin c derivatives with peptide, preparation method thereof and composition comprising the same | PEPTRON CO., LTD. (KR) | 2007-04-26 | — | — | US | disclosed |
| EP-1618125-A1 | VITAMIN C DERIVATIVES WITH PEPTIDE, PREPARATION METHOD THEREOF AND COMPOSITION COMPRISING THE SAME | Petron Co., Ltd. (KR) | 2006-01-25 | — | — | EP | disclosed |
| WO-2004096837-A1 | VITAMIN C DERIVATIVES WITH PEPTIDE, PREPARATION METHOD THEREOF AND COMPOSITION COMPRISING THE SAME | PEPTRON CO., LTD (KR) | 2004-11-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250170043-A1 | KIT OF COSMETIC COMPOSITIONS | CHKA, CHKB, SGMS2 | SLC15A2 3889/4885ITGB3 1265/4885ITGA2B 402/4885 |
| US-20250161200-A1 | COSMETIC COMPOSITION COMPRISING EXTRACT OF OPHIOPOGON JAPONICUS AND AT LEAST ONE CERAMIDE | SGMS2, SGMS1, CERS2 | SLC15A2 4657/4885ITGB3 1777/4885ITGA2B 2382/4885 |
| US-20070093425-A1 | Vitamin c derivatives with peptide, preparation method thereof and composition comprising the same | PROC, CTRC, GC | SLC15A2 1887/4885ITGB3 3437/4885ITGA2B 4625/4885 |
| US-20250161201-A1 | COSMETIC COMPOSITION | CYP19A1, SHBG, HSD17B11 | SLC15A2 4269/4885ITGB3 925/4885ITGA2B 1252/4885 |
| US-20250152494-A1 | COSMETIC COMPOSITION CONTAINING RETINOID, EXTRACT OF CENTELLA ASIATICA AND A DIPEPTIDE | RARA, RARG, RARB | SLC15A2 2929/4885ITGB3 4467/4885ITGA2B 4481/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.